Myocyte-specific enhancer factor 2D promotes tumorigenesis and progression in tongue squamous cell carcinoma
Authors:
- 1 January 2020
- journal article
- research article
- Vol. 13 (5) , 934-943
Abstract
Tongue squamous cell carcinoma (TSCC) ranks as one of the most common cancers worldwide and has a poor prognosis. Myocyte-specific enhancer factor 2 (MEF2D) has recently been considered as a novel factor involved in cancer development. In the present study, the function and underlying mechanism of MEF2D in TSCC were investigated. The levels of MEF2D mRNA and protein were determined in human TSCC samples by RT-qPCR and western blot, respectively. The interaction between MEF2D expression and clinicopathologic features was evaluated by IHC and analysis of clinical information. MEF2D-mediated effects on proliferation, migration, and invasion were explored in TSCC cells after transfection with MEF2D-siRNA. The results showed higher expression of MEF2D at both the mRNA and protein levels in TSCC carcinoma tissues than in paracarcinoma tissues. Furthermore, high expression of MEF2D was positively correlated with tumor differentiation and lymphatic metastasis. MEF2D knocked down TSCCA cells also had reduced proliferative, migratory, and invasive abilities compared to those of control cells. Together, these data confirmed that knockdown of MEF2D might suppress the growth and metastasis of TSCC, which further indicated that MEF2D might serve as a therapeutic target for TSCC treatment.Keywords
This publication has 33 references indexed in Scilit:
- Prognostic significance of lymph node density in squamous cell carcinoma of the tongueHead & Neck, 2015
- Alternative Splicing of MEF2C pre-mRNA Controls Its Activity in Normal Myogenesis and Promotes Tumorigenicity in Rhabdomyosarcoma CellsJournal of Biological Chemistry, 2015
- miR-26b is downregulated in human tongue squamous cell carcinoma and regulates cell proliferation and metastasis through a COX-2-dependent mechanismOncology Reports, 2014
- Myocyte enhancer factor 2C regulation of hepatocellular carcinoma via vascular endothelial growth factor and Wnt/β-catenin signalingOncogene, 2014
- Myocyte enhancer factor 2C in hematopoiesis and leukemiaOncogene, 2013
- Regulation of Skeletal Muscle Sarcomere Integrity and Postnatal Muscle Function by Mef2cMolecular and Cellular Biology, 2007
- Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2007
- Marked reduction of focal adhesion kinase, serum response factor and myocyte enhancer factor 2C, but increase in RhoA and myostatin in the hindlimb dy mouse musclesActa Neuropathologica, 2004
- Demographics and occurrence of oral and pharyngeal cancersThe Journal of the American Dental Association, 2001
- Myocyte Enhancer Factor 2C and Nkx2–5 Up-regulate Each Other's Expression and Initiate Cardiomyogenesis in P19 CellsJournal of Biological Chemistry, 1998